The Japan Morning Surge-1 (JMS-1) study: Protocol description

Hypertension Research

Volumn 29, Issue 3, 2006, Pages 153-159

  Ishikawa, Joji ^a   Hoshide, Satoshi ^a   Shibasaki, Seiichi ^b   Matsui, Yoshio ^b   Kabutoya, Tomoyuki ^c   Eguchi, Kazuo ^a,c   Ishikawa, Shizukiyo ^a   Pickering, Thomas G ^d   Shimada, Kazuyuki ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Miwa Municipal Hospital   (Japan)

^c Chichibu City Hospital   (Japan)

^d Department of Orthopaedic Surgery   (United States)

Author keywords

Doxazosin; Hypertensive target organ damage; Morning hypertension; Multicenter randomized clinical trial

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DOXAZOSIN;

ADRENERGIC SYSTEM; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN INFARCTION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DOSE RESPONSE; HEART LEFT VENTRICLE MASS; HOME CARE; HUMAN; HYPERTENSION; INTERVIEW; JAPAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MORNING HYPERTENSION; MULTICENTER STUDY; ORGAN INJURY; OUTPATIENT CARE; PATHOGENESIS; PATIENT SELECTION; PHYSICIAN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TELEPHONE; UNSPECIFIED SIDE EFFECT; URINARY EXCRETION;

ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CIRCADIAN RHYTHM; CLINICAL PROTOCOLS; CREATINE; DOXAZOSIN; HUMANS; HYPERTENSION; JAPAN; NATRIURETIC PEPTIDE, BRAIN; RANDOMIZED CONTROLLED TRIALS;

EID: 33646039773     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.153     Document Type: Article

References (39)

1. Kuwajima I, Mitani K, Miyao M, Suzuki Y, Kuramoto K, Ozawa T: Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: relation to arising time. Am J Hypertens 1995; 8: 29-33.
2. Ikeda T, Gomi T, Shibuya Y, et al: Morning rise in blood pressure is a predictor of left ventricular hypertrophy in treated hypertensive patients. Hypertens Res 2004; 27: 939-46.
3. Kamoi K, Miyakoshi M, Soda S, Kaneko S, Nakagawa O: Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care 2002; 25: 2218-2223.
4. Kario K, Pickering TG, Umeda Y, et al: Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-1406.
5. Tachibana R, Tabara Y, Kondo I, Miki T, Kohara K: Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens Res 2004; 27: 633-639.
6. Marfella R, Gualdiero P, Siniscalchi M, et al: Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension 2003; 41: 237-243.
7. Kario K, Pickering TG, Hoshide S, et al: Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens 2004; 17: 668-675.
8. Pickering TG, Levenstein M, Walmsley P, Hypertension and Lipid Trial Study Group: Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT Study. Am J Hypertens 1994; 7: 844-847.
9. Staessen JA, Den Hond E, Celis H, et al: Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA 2004; 291: 955-964.
10. Kario K: Time for focus on morning hypertension: pitfall of current antihypertensive medication. Am J Hypertens 2005; 18: 149-151.
11. Ishikawa J, Kario K, Hoshide S, et al: Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients: Jichi Morning Hypertension Research (J-MORE) Study. Am J Hypertens 2005; 18: 958-965.
12. Nishikimi T, Yoshihara F, Morimoto A, et al: Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
13. Lubien E, DeMaria A, Krishnaswamy P, et al: Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
14. Mak GS, DeMaria A, Clopton P, Maisel AS: Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J 2004; 148: 895-902.
15. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation 2004; 109: 3176-3181.
16. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P: N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005; 293: 1609-1616.
17. Wang TJ, Evans JC, Meigs JB, et al: Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370-1376.
18. Pascual JM, Rodilla E, Gonzalez C, Perez-Hoyos S, Redon J: Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension 2005; 45: 1125-1130.
19. Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T: Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 2004; 27: 471-477.
20. Cirillo M, Senigalliesi L, Laurenzi M, et al: Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: the Gubbio Population Study. Arch Intern Med 1998; 158: 1933-1939.
21. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS: Urinary albumin excretion: an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992-1997.
22. Klausen KP, Scharling H, Jensen G, Jensen JS: New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension 2005; 46: 33-37.
23. Imai Y, Otsuka K, Kawano Y, et al: Japanese Society of Hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26: 771-782.
24. Anwar YA, Giacco S, McCabe EJ, Tendler BE, White WB: Evaluation of the efficacy of the Omron HEM-737 IntelliSense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press Monit 1998; 3: 261-265.
25. Chobanian AV, Bakris GL, Black HR, et al: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
26. Cifkova R, Erdine S, Fagard R, et al: Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003; 21: 1779-1786.
27. Whitworth JA: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
28. Staessen JA, Bieniaszewski L, Buntinx F, et al: The trough-to-peak ratio as an instrument to evaluate antihypertensive drugs. Hypertension 1995; 26: 942-949.
29. Kawabe H, Saito I, Saruta T: Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population. Hypertens Res 2005; 28: 491-498.
30. Pickering TG, Davidson K, Gerin W, Schwartz JE: Masked hypertension. Hypertension 2002; 40: 795-796.
31. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB: Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131: 564-572.
32. Bobrie G, Chatellier G, Genes N, et al: Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-1349.
33. Uchida H, Nakamura Y, Kaihara M, et al: Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension. Hypertens Res 2004; 27: 545-550.
34. Sega R, Facchetti R, Bombelli M, et al: Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study. Circulation 2005; 111: 1777-1783.
35. White WB: Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med 2003; 348: 2377-2378.
36. Otto ME, Svatikova A, Barretto RBdM, et al: Early morning attenuation of endothelial function in healthy humans. Circulation 2004; 109: 2507-2510.
37. Kuroda T, Kario K, Hoshide S, et al: Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res 2004; 27: 15-20.
38. Ohkubo T, Hozawa A, Yamaguchi J, et al: Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20: 2183-2189.
39. Hoshide S, Kario K, Hoshide Y, et al: Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 2003; 16: 434-438.